CELZ logo

CELZ EBITDA

Annual EBITDA

-$5.53 M
+$4.63 M+45.57%

December 1, 2023


Summary


Performance

CELZ EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCELZprofitabilitymetrics:

Quarterly EBITDA

-$1.08 M
+$515.60 K+32.31%

September 1, 2024


Summary


Performance

CELZ Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCELZprofitabilitymetrics:

TTM EBITDA

-$5.43 M
+$439.80 K+7.49%

September 1, 2024


Summary


Performance

CELZ TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCELZprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CELZ EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+45.6%-6.7%+0.2%
3 y3 years+84.2%+4.5%+5.4%
5 y5 years+55.0%+4.5%+5.4%

CELZ EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-123.4%+45.6%-8.3%+82.7%-123.0%+46.5%
5 y5-year-123.4%+84.2%-103.8%+97.2%-123.0%+84.5%
alltimeall time-123.4%+84.2%-103.8%+97.2%-123.0%+84.5%

Creative Medical Technology Holdings EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.08 M(-32.3%)
-$5.43 M(-7.5%)
Jun 2024
-
-$1.60 M(+57.7%)
-$5.87 M(+7.8%)
Mar 2024
-
-$1.01 M(-42.0%)
-$5.45 M(-0.3%)
Dec 2023
-$5.53 M(-45.6%)
-$1.75 M(+14.9%)
-$5.46 M(-45.2%)
Sep 2023
-
-$1.52 M(+30.0%)
-$9.97 M(+5.5%)
Jun 2023
-
-$1.17 M(+13.6%)
-$9.45 M(-6.0%)
Mar 2023
-
-$1.03 M(-83.6%)
-$10.05 M(-1.0%)
Dec 2022
-$10.15 M(-143.1%)
-$6.25 M(+527.1%)
-$10.15 M(+89.9%)
Sep 2022
-
-$997.40 K(-43.6%)
-$5.35 M(+9.9%)
Jun 2022
-
-$1.77 M(+56.2%)
-$4.86 M(-15.3%)
Mar 2022
-
-$1.13 M(-21.9%)
-$5.74 M(-124.4%)
Dec 2021
$23.58 M(-167.3%)
-
-
Dec 2021
-
-$1.45 M(+181.3%)
$23.58 M(-278.0%)
Sep 2021
-
-$515.30 K(-80.5%)
-$13.25 M(+10.1%)
Jun 2021
-
-$2.65 M(-109.4%)
-$12.04 M(+10.3%)
Mar 2021
-
$28.20 M(-173.6%)
-$10.92 M(-68.8%)
Dec 2020
-$35.03 M(+433.9%)
-$38.28 M(-5562.9%)
-$35.03 M(+2207.1%)
Sep 2020
-
$700.80 K(-145.9%)
-$1.52 M(-62.9%)
Jun 2020
-
-$1.53 M(-137.4%)
-$4.09 M(+91.1%)
Mar 2020
-
$4.08 M(-185.5%)
-$2.14 M(-67.4%)
Dec 2019
-$6.56 M(-46.5%)
-$4.77 M(+155.0%)
-$6.56 M(-1333.8%)
Sep 2019
-
-$1.87 M(-544.3%)
$531.80 K(-56.2%)
Jun 2019
-
$421.30 K(-224.8%)
$1.21 M(-123.3%)
Mar 2019
-
-$337.50 K(-114.5%)
-$5.22 M(-57.5%)
Dec 2018
-$12.27 M(+441.7%)
$2.32 M(-295.1%)
-$12.27 M(-22.7%)
Sep 2018
-
-$1.19 M(-80.2%)
-$15.88 M(+8.7%)
Jun 2018
-
-$6.01 M(-18.6%)
-$14.61 M(+55.2%)
Mar 2018
-
-$7.39 M(+472.9%)
-$9.42 M(+315.7%)
Dec 2017
-$2.27 M(+201.9%)
-$1.29 M(-1656.0%)
-$2.27 M(+94.5%)
Sep 2017
-
$82.90 K(-110.1%)
-$1.16 M(-20.1%)
Jun 2017
-
-$820.30 K(+244.4%)
-$1.46 M(+72.9%)
Mar 2017
-
-$238.20 K(+25.8%)
-$843.00 K(+12.4%)
Dec 2016
-$750.30 K
-$189.30 K(-9.8%)
-$750.30 K(+32.3%)
Sep 2016
-
-$209.90 K(+2.1%)
-$567.30 K(+57.1%)
Jun 2016
-
-$205.60 K(+41.3%)
-$361.10 K(+126.7%)
DateAnnualQuarterlyTTM
Mar 2016
-
-$145.50 K(+2209.5%)
-$159.30 K(+665.9%)
Dec 2015
-$20.80 K(+7.2%)
-$6300.00(+70.3%)
-$20.80 K(+11.2%)
Sep 2015
-
-$3700.00(-2.6%)
-$18.70 K(+0.5%)
Jun 2015
-
-$3800.00(-45.7%)
-$18.60 K(+1.1%)
Mar 2015
-
-$7000.00(+66.7%)
-$18.40 K(-5.2%)
Dec 2014
-$19.40 K(-3.5%)
-$4200.00(+16.7%)
-$19.40 K(+0.5%)
Sep 2014
-
-$3600.00(0.0%)
-$19.30 K(0.0%)
Jun 2014
-
-$3600.00(-55.0%)
-$19.30 K(-2.0%)
Mar 2014
-
-$8000.00(+95.1%)
-$19.70 K(-2.5%)
Dec 2013
-$20.10 K(0.0%)
-$4100.00(+13.9%)
-$20.20 K(-1.9%)
Sep 2013
-
-$3600.00(-10.0%)
-$20.60 K(-2.4%)
Jun 2013
-
-$4000.00(-52.9%)
-$21.10 K(+1.4%)
Mar 2013
-
-$8500.00(+88.9%)
-$20.80 K(+3.5%)
Dec 2012
-$20.10 K(+1.5%)
-$4500.00(+9.8%)
-$20.10 K(-5.2%)
Sep 2012
-
-$4100.00(+10.8%)
-$21.20 K(+2.9%)
Jun 2012
-
-$3700.00(-52.6%)
-$20.60 K(+1.5%)
Mar 2012
-
-$7800.00(+39.3%)
-$20.30 K(+2.5%)
Dec 2011
-$19.80 K(+38.5%)
-$5600.00(+60.0%)
-$19.80 K(+15.1%)
Sep 2011
-
-$3500.00(+2.9%)
-$17.20 K(+4.2%)
Jun 2011
-
-$3400.00(-53.4%)
-$16.50 K(+15.4%)
Mar 2011
-
-$7300.00(+143.3%)
-$14.30 K(0.0%)
Dec 2010
-$14.30 K(-53.3%)
-$3000.00(+7.1%)
-$14.30 K(-30.2%)
Sep 2010
-
-$2800.00(+133.3%)
-$20.50 K(+1.0%)
Jun 2010
-
-$1200.00(-83.6%)
-$20.30 K(-28.0%)
Mar 2010
-
-$7300.00(-20.7%)
-$28.20 K(-7.8%)
Dec 2009
-$30.60 K(-40.4%)
-$9200.00(+253.8%)
-$30.60 K(-8.1%)
Sep 2009
-
-$2600.00(-71.4%)
-$33.30 K(-38.1%)
Jun 2009
-
-$9100.00(-6.2%)
-$53.80 K(-4.1%)
Mar 2009
-
-$9700.00(-18.5%)
-$56.10 K(+8.7%)
Dec 2008
-$51.30 K(+277.2%)
-$11.90 K(-48.5%)
-$51.60 K(+7.1%)
Sep 2008
-
-$23.10 K(+102.6%)
-$48.20 K(+63.9%)
Jun 2008
-
-$11.40 K(+119.2%)
-$29.40 K(+63.3%)
Mar 2008
-
-$5200.00(-38.8%)
-$18.00 K(+40.6%)
Dec 2007
-$13.60 K(+871.4%)
-$8500.00(+97.7%)
-$12.80 K(+197.7%)
Sep 2007
-
-$4300.00
-$4300.00
Dec 2006
-$1400.00
-
-

FAQ

  • What is Creative Medical Technology Holdings annual EBITDA?
  • What is the all time high annual EBITDA for Creative Medical Technology Holdings?
  • What is Creative Medical Technology Holdings annual EBITDA year-on-year change?
  • What is Creative Medical Technology Holdings quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Creative Medical Technology Holdings?
  • What is Creative Medical Technology Holdings quarterly EBITDA year-on-year change?
  • What is Creative Medical Technology Holdings TTM EBITDA?
  • What is the all time high TTM EBITDA for Creative Medical Technology Holdings?
  • What is Creative Medical Technology Holdings TTM EBITDA year-on-year change?

What is Creative Medical Technology Holdings annual EBITDA?

The current annual EBITDA of CELZ is -$5.53 M

What is the all time high annual EBITDA for Creative Medical Technology Holdings?

Creative Medical Technology Holdings all-time high annual EBITDA is $23.58 M

What is Creative Medical Technology Holdings annual EBITDA year-on-year change?

Over the past year, CELZ annual EBITDA has changed by +$4.63 M (+45.57%)

What is Creative Medical Technology Holdings quarterly EBITDA?

The current quarterly EBITDA of CELZ is -$1.08 M

What is the all time high quarterly EBITDA for Creative Medical Technology Holdings?

Creative Medical Technology Holdings all-time high quarterly EBITDA is $28.20 M

What is Creative Medical Technology Holdings quarterly EBITDA year-on-year change?

Over the past year, CELZ quarterly EBITDA has changed by -$68.10 K (-6.73%)

What is Creative Medical Technology Holdings TTM EBITDA?

The current TTM EBITDA of CELZ is -$5.43 M

What is the all time high TTM EBITDA for Creative Medical Technology Holdings?

Creative Medical Technology Holdings all-time high TTM EBITDA is $23.58 M

What is Creative Medical Technology Holdings TTM EBITDA year-on-year change?

Over the past year, CELZ TTM EBITDA has changed by +$12.80 K (+0.23%)